Hospital News and Research

RSS

Intravenous Phenoxodiol-cisplatin combination well tolerated in platinum resistant ovarian cancer

Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from a Phase II clinical trial of intravenous Phenoxodiol in combination with cisplatin in women with platinum-resistant ovarian cancer.

21 Mar 2011

Roundup: Kan., Calif. budget cuts; Texas NICU costs; Katrina trial; Medco CalPERS contract 'dumped'

This list of programs cut in the California state budget includes a 10 percent reduction in what the state pays for Medi-Cal patients at all long-term care facilities $172.3 million and a 10 percent reduction in what the state pays to physicians who see people on Medi-Cal.

21 Mar 2011

NasVax reports positive results from Phase 2a trial of oral immunotherapy for non-alcoholic steatohepatitis

NasVax announces the success of a Phase 2a clinical trial of a new oral immunotherapy for non-alcoholic steatohepatitis (NASH), an inflammatory disease associated with fatty liver disease and the metabolic syndrome.

21 Mar 2011

ACS announces definitive agreement to acquire CredenceHealth

Affiliated Computer Services, Inc. (ACS), A Xerox Company, today announced a definitive agreement to acquire CredenceHealth, Inc., creating a simple way for healthcare providers to use patient information to predict and prevent complications.

21 Mar 2011

Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced results for the year ended December 31, 2010.

21 Mar 2011

Innovative algorithm for AEDs distinguishes betweeen adult and child arrhythmias

Ventricular Fibrillation (VF) is a series of intense and disordered contractions of the ventricles (they are located in the lower part of the heart). In 40 % of respiratory arrests suffered outside a hospital, it was shown that the first cardiac rhythm corresponds to VF, and the only manner to combat it is with electric discharges provided by defibrillation. This

21 Mar 2011

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

Insmed Incorporated, a biopharmaceutical company, announced today that the Company's Investigational New Drug Application (IND) to conduct a pivotal Phase 3 clinical trial of ARIKACE™ (liposomal amikacin for inhalation) in nontuberculous mycobacteria (NTM) lung infections has been cleared by the U.S. Food and Drug Administration (FDA).

21 Mar 2011

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.

21 Mar 2011

Organic, non-toxic, biodegradable nanoparticle uses light and heat to treat cancer

A team of scientists from Princess Margaret Hospital have created an organic nanoparticle that is completely non-toxic, biodegradable and nimble in the way it uses light and heat to treat cancer and deliver drugs.

21 Mar 2011

Elevations in 5 amino acids may signal future disease risk

Measuring the levels of small molecules in the blood may be able to identify individuals at elevated risk of developing type 2 diabetes as much as a decade before symptoms of the disorder appear.

21 Mar 2011

New synchrotron-based imaging technique offers more detailed chemical images

With intensity a million times brighter than sunlight, a new synchrotron-based imaging technique offers high-resolution pictures of the molecular composition of tissues with unprecedented speed and quality. Carol Hirschmugl, a physicist at the University of Wisconsin-Milwaukee (UWM), led a team of researchers from UWM, the University of Illinois at Urbana-Champaign and University of Illinois at Chicago (UIC) to demonstrate these new capabilities.

21 Mar 2011

Scots drinking too much: Report

According to a survey by Britains’s NHS, people of Scotland are drinking too much. Deaths related to alcohol are at an all time high in the country. The survey finds that Scots are consuming an additional 1.2 litres of pure alcohol per year. Alcohol-related deaths and hospital admissions are four times higher since the 1980’s. A recent report has also showed that alcohol related deaths were six-fold higher among the poor people.

21 Mar 2011

Asthma an diabetes go hand in hand: Research

A new study has found that people with asthma may have a higher risk of developing diabetes and heart disease. The study looked at the relationship between asthma and four other inflammatory conditions.

21 Mar 2011

Ibuprofen - painkiller toxicity warning

In a recent development, doctors have warned regarding the possibly toxicities of common pain killer Ibuprofen adding that it can lead to a potentially fatal condition which can be triggered, in rare cases, by even a standard dose. The condition in question is called renal tubular acidosis (RTA). The research is published in the Medical Journal of Australia.

21 Mar 2011

Intensive weekends: Higher death rates at ICUs over weekends

The study spanned over eight-years and 245,000 admissions to 41 intensive care units throughout Australia to come to this conclusion. It is published in The Medical Journal of Australia. It also showed that this pattern persisted even after accounting for severity of illness.

21 Mar 2011

Potential bias seen in informed consent language when describing trials, say researchers

When presented with different terms to describe a clinical trial, parents were far more likely to consent to enroll their child if it was called a "research study" than if it was called a "medical experiment" or a "research project," in large part because they perceived the former as safer, even though that was not necessarily the case, according to a report in IRB: Ethics & Human Research.

19 Mar 2011

CAPCC, Health Canada, Safe Kids Canada remind parents about dangers of unintentional poisoning

Kathleen Wong was frantic when her three-year-old daughter Kiana took a nibble from one of her grandfather's diabetes tablets. "We were visiting my father and he had put his medication out on the counter to take later," recalls Kathleen. "My daughter got up on a chair near the counter and took a bite of one of the pills."

19 Mar 2011

CHMP recommends approval of Centralized Marketing Authorization for Cinryze

ViroPharma Incorporated today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion at its plenary meeting in March 2011 recommending approval of a Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.

19 Mar 2011

BioMarin announces preliminary results from ADAPT in patients suffering from PKU

BioMarin Pharmaceutical Inc. announced today preliminary results from ADAPT (A Diversified Approach for PKU Treatment) in an abstract (Abstract #91, Mental Health Screening in Phenylketoniuria Clinic) presented by Barbara Burton, MD at the 2011 annual American College of Medical Genetics conference in Vancouver, Canada.

19 Mar 2011

AGS honors Boston University professor with Memorial Award for geriatrics education

The American Geriatrics Society has awarded Sharon A. Levine, MD, AGSF, with the 2011 Dennis W. Jahnigen Memorial Award, given annually to an AGS member who has provided outstanding leadership in advancing geriatrics education in health professions schools.

19 Mar 2011

Hospital News and Research

Intravenous Phenoxodiol-cisplatin combination well tolerated in platinum resistant ovarian cancer

Roundup: Kan., Calif. budget cuts; Texas NICU costs; Katrina trial; Medco CalPERS contract 'dumped'

NasVax reports positive results from Phase 2a trial of oral immunotherapy for non-alcoholic steatohepatitis

ACS announces definitive agreement to acquire CredenceHealth

Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million

Innovative algorithm for AEDs distinguishes betweeen adult and child arrhythmias

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

First clinical use of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on lower profile delivery system

Organic, non-toxic, biodegradable nanoparticle uses light and heat to treat cancer

Elevations in 5 amino acids may signal future disease risk

New synchrotron-based imaging technique offers more detailed chemical images

Scots drinking too much: Report

Asthma an diabetes go hand in hand: Research

Ibuprofen - painkiller toxicity warning

Intensive weekends: Higher death rates at ICUs over weekends

Potential bias seen in informed consent language when describing trials, say researchers

CAPCC, Health Canada, Safe Kids Canada remind parents about dangers of unintentional poisoning

CHMP recommends approval of Centralized Marketing Authorization for Cinryze

BioMarin announces preliminary results from ADAPT in patients suffering from PKU

AGS honors Boston University professor with Memorial Award for geriatrics education

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News